Pre-existing cardiovascular disease, acute kidney injury, and cardiovascular outcomes in hospitalized blacks with COVID-19 infection

被引:0
|
作者
Egbuche, Obiora [1 ]
Jegede, Opeyemi [2 ]
Abe, Temidayo [3 ]
Wagle, Bivek [3 ]
Huynh, Ky [3 ]
Hayes, Dolphurs [3 ]
Campbell, Martin Luther [3 ]
Mezue, Kenechukwu [4 ]
Ram, Pradhum [5 ]
Nwokike, Shirley, I [6 ]
Desai, Rupak [7 ]
Effoe, Valery [1 ]
Kpodonu, Jacques [8 ]
Morgan, Jayne [9 ]
Ofili, Elizabeth [1 ]
Onwuanyi, Anekwe [1 ]
Echols, Melvin R. [1 ]
机构
[1] Morehouse Sch Med, Div Cardiovasc Dis, 720 Westview Dr SW, Atlanta, GA 30310 USA
[2] Univ North Texas, Dept Biostat & Epidemiol, Ctr Hlth Sci, Ft Worth, TX 76107 USA
[3] Morehouse Sch Med, Dept Internal Med, Atlanta, GA 30310 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Div Nucl Cardiol, Boston, MA 02114 USA
[5] Emory Univ, Div Cardiovasc Dis, Sch Med, Atlanta, GA 30322 USA
[6] Med Coll Georgia, Dept Internal Med, Augusta, GA 30912 USA
[7] Atlanta VA Med Ctr, Div Cardiovasc Dis, Decatur, GA 30033 USA
[8] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Cardiac Surg, Boston, MA 02215 USA
[9] Piedmont Healthcare Inc, Div Qual & Safety, Atlanta, GA 30309 USA
来源
AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE | 2021年 / 11卷 / 02期
关键词
Pre-existing CVD; acute kidney injury; mortality; COVID-19; blacks;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Corona Virus 19 (COVID-19) infection is associated with worse outcomes in blacks, although the mechanisms are unclear. We sought to determine the significance of black race, pre-existing cardiovascular disease (pCVD), and acute kidney injury (AKI) on cardiopulmonary outcomes and in-hospital mortality of COVID-19 patients. Methods: We conducted a retrospective cohort study of blacks with/without pCVD and with/without in-hospital AKI, hospitalized within Grady Memorial Hospital in Georgia between February and July 2020, who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on qualitative polymerase-chain-reaction assay. The primary outcome was a composite of in-hospital cardiac events. Results: Of the 293 patients hospitalized with COVID-19 in this study, 71 were excluded from the primary analysis (for race/ethnicity other than black non-Hispanic). Of the 222 hospitalized COVID-19 patients included in our analyses, 41.4% were female, 78.8% had pCVD, and 30.6% developed AKI during the admission. In multivariable analyses, pCVD (OR 4.7, 95% C1 1.5-14.8, P=0.008) and AKI (OR 2.7, 95% CI 1.3-5.5, P=0.006) were associated with increased odds of inhospital cardiac events. AKI was associated with increased odds of in-hospital mortality (OR 8.9, 95% CI 3.3-23.9, P<0.0001). The presence of AKI was associated with increased odds of ICU stay, mechanical ventilation, and acute respiratory distress syndrome (ARDS). Conclusion: pCVD and AKI were associated with higher risk of in-hospital cardiac events, and AKI was associated with a higher risk of in-hospital mortality in blacks.
引用
收藏
页码:212 / 221
页数:10
相关论文
共 50 条
  • [21] Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID-19 infection
    Fisher, Lori-Ann
    Asnani, Monika
    EJHAEM, 2023, 4 (01): : 37 - 44
  • [22] Outcomes of Hospitalized Patients With COVID-19 With Acute Kidney Injury and Acute Cardiac Injury
    Lu, Justin Y.
    Buczek, Alexandra
    Fleysher, Roman
    Hoogenboom, Wouter S.
    Hou, Wei
    Rodriguez, Carlos J.
    Fisher, Molly C.
    Duong, Tim Q.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [23] Impact of pre-existing respiratory disease on radiological outcomes in COVID-19 pneumonia
    Kamil, H. G.
    Abdelaziz, A.
    Ponnuswamy, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [24] THROMBOEMBOLIC OUTCOMES IN HOSPITALIZED PATIENTS WITH UNDERLYING CARDIOVASCULAR DISEASE AND COVID-19
    Khairani, Candrika
    Barns, Briana M.
    Pfeferman, Mariana
    Snyder, Julia E.
    Goldhaber, Samuel
    Piazza, Gregory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3139 - 3139
  • [25] Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury
    Ng, Jia H.
    Hirsch, Jamie S.
    Hazzan, Azzour
    Wanchoo, Rimda
    Shah, Hitesh H.
    Malieckal, Deepa A.
    Ross, Daniel W.
    Sharma, Purva
    Sakhiya, Vipulbhai
    Fishbane, Steven
    Jhaveri, Kenar D.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (02) : 204 - +
  • [26] COVID-19 in patients with pre-existing chronic liver disease–predictors of outcomes
    Dinesh Walia
    Anoop Saraya
    Deepak Gunjan
    World Journal of Virology, 2023, (01) : 30 - 43
  • [27] Impact of COVID-19 on pre-existing liver disease
    Abdo-Francis, Juan M.
    Moreno-Alcantar, Rosalba
    Perez-Hernandez, Jose L.
    Remes-Troche, Jose M.
    Velasco, Antonio Velarde-Ruiz
    Cerda-Reyes, Eira
    de la Tijera, Fatima Higuera
    Castro-Narro, Graciela
    CIRUGIA Y CIRUJANOS, 2024, 92 (01): : 131 - 136
  • [28] CARDIOVASCULAR MORTALITY RATES IN PEOPLE WITH END-STAGE KIDNEY DISEASE WITH PRE-EXISTING CARDIOVASCULAR DISEASE
    De La Mata, N.
    Kelly, P.
    Webster, A. C.
    NEPHROLOGY, 2018, 23 : 43 - 43
  • [29] Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China
    Wang, Tao
    Tang, Ruidi
    Ruan, Honglian
    Chen, Ruchong
    Zhang, Zili
    Sang, Ling
    Su, Xi
    Yi, Shuting
    Ni, Zhengyi
    Hu, Yu
    Liu, Lei
    Shan, Hong
    Lei, Chunliang
    Peng, Yixiang
    Liu, Chunli
    Li, Jing
    Hong, Cheng
    Zhang, Nuofu
    Zhong, Nanshan
    Li, Shiyue
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (08): : 915 - 924
  • [30] Impact of pre-existing depression on severe COVID-19 outcomes
    Sha, Meng
    Qian, Yong-bing
    Xia, Qiang
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (08) : 388 - 389